Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

50
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
50
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

57
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
57
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

673
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
673
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

301
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
301
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.9K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Identification of Key Osteoarthritis-Associated Genes Based on DNA Methylation.

International journal of molecular sciences·2026
Same author

MEMO-Stab2: Multi-View Sequence-Based Deep Learning Framework for Predicting Mutation-Induced Stability Changes in Transmembrane Proteins.

Journal of chemical information and modeling·2025
Same author

Heterogeneous Graph Contrastive Learning with Graph Diffusion for Drug Repositioning.

Journal of chemical information and modeling·2025
Same author

Degenerative Disease Diagnosis and Analysis Based on Tissue Specificity of DNA Methylation.

International journal of molecular sciences·2025
Same author

MMPD-DTA: Integrating Multi-Modal Deep Learning with Pocket-Drug Graphs for Drug-Target Binding Affinity Prediction.

Journal of chemical information and modeling·2025
Same author

Research on Prediction of Multiple Degenerative Diseases and Biomarker Screening Based on DNA Methylation.

International journal of molecular sciences·2025
Same journal

PFASGroups: An Open-Source Framework for Automated Identification, Structural Classification, and Prioritization of Per- and Polyfluoroalkyl Substances.

Journal of chemical information and modeling·2026
Same journal

DeepKbhb: Context-Aware Prediction of Human Lysine β-Hydroxybutyrylation Sites.

Journal of chemical information and modeling·2026
Same journal

HyperDC: A Non-Uniform Hypergraph Framework for Dual- and Higher-Order Drug Combination Recommendation Across Diverse Complex Diseases.

Journal of chemical information and modeling·2026
Same journal

Correction to "AstraMEV (AI-Guided Structural Assembly of Multi-Epitope Vaccines) Against Infectious Bronchitis Virus".

Journal of chemical information and modeling·2026
Same journal

MolPy: A Large Language Model-Friendly Toolkit for Reactive Topology Editing in Polymer Simulations.

Journal of chemical information and modeling·2026
Same journal

Molecular Mechanisms of KIT Receptor Dimerization and Oncogenic Activation Revealed by Multiscale Simulations.

Journal of chemical information and modeling·2026
查看所有相关文章

相关实验视频

Updated: Mar 11, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.8K

MML-DTI:多元学习与超标图神经网络用于增强药物向相互作用预测.

Haotian Guan1,2, Tian Bai1,2, Chuande Yang3,2

  • 1College of Computer Science and Technology, Jilin University, No. 2699 Qianjin Street, Changchun, Jilin 130012, China.

Journal of chemical information and modeling
|March 9, 2026
PubMed
概括
此摘要是机器生成的。

这项研究引入了一种新的多重学习框架,用于预测药物向相互作用 (DTI). 通过利用超标几何学,该模型有效地捕获分层生物数据特征,优于现有的基于欧几里德的方法.

更多相关视频

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.7K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.8K

相关实验视频

Last Updated: Mar 11, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.8K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.7K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.8K

科学领域:

  • 计算生物学是一种计算生物学.
  • 药物发现 药物发现
  • 机器学习 机器学习

背景情况:

  • 准确的药物向相互作用 (DTI) 预测对于药物发现和重新定位至关重要.
  • 现有的深度学习模型由于其欧几里德空间设计,经常与生物数据的等级性质作斗争.
  • 超标空间为表现复杂的等级关系提供了一个有希望的替代方案.

研究的目的:

  • 为增强DTI预测开发一种新的多元学习框架.
  • 有效地整合药物和目标的多式联运特征.
  • 为了利用超标几何学来更好地表示生物数据.

主要方法:

  • 提出了一个多重的学习框架,整合了超标空间和欧几里德空间.
  • 采用过度图神经网络 (HGNN) 来从分子图中提取层次特征.
  • 使用多重多重特征融合模块来结合HGNN特征,化学指纹和语言模型嵌入.

主要成果:

  • 与最新的基于欧几里德的DTI预测方法相比,拟议的框架实现了更高的性能.
  • 从非欧几里德生物数据中捕捉层次特征,证明了超标几何学的优势.
  • 验证了多重特征融合对DTI预测的有效性.

结论:

  • 超标几何学通过有效地建模层次数据结构,为DTI预测提供了显著的好处.
  • 多种特征的融合方法显示了推进DTI预测的巨大潜力.
  • 这一框架为未来的药物发现和重新定位工作提供了一个有希望的方向.